Skip to main content

and
  1. Article

    Open Access

    Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

    Advanced prostate cancer initially responds to hormonal treatment, but ultimately becomes resistant and requires more potent therapies. One mechanism of resistance observed in around 10–20% of these patients i...

    Joanna Cyrta, Anke Augspach, Maria Rosaria De Filippo in Nature Communications (2020)

  2. Article

    Open Access

    Patient derived organoids to model rare prostate cancer phenotypes

    A major hurdle in the study of rare tumors is a lack of existing preclinical models. Neuroendocrine prostate cancer is an uncommon and aggressive histologic variant of prostate cancer that may arise de novo or...

    Loredana Puca, Rohan Bareja, Davide Prandi, Reid Shaw in Nature Communications (2018)

  3. No Access

    Article

    A highly specific SpCas9 variant is identified by in vivo screening in yeast

    Evolved SpCas9 variant evoCas9 has improved specificity and retains near wild-type on-target activity.

    Antonio Casini, Michele Olivieri, Gianluca Petris, Claudia Montagna in Nature Biotechnology (2018)

  4. Article

    Open Access

    Hit and go CAS9 delivered through a lentiviral based self-limiting circuit

    In vivo application of the CRISPR-Cas9 technology is still limited by unwanted Cas9 genomic cleavages. Long-term expression of Cas9 increases the number of genomic loci non-specifically cleaved by the nuclease. H...

    Gianluca Petris, Antonio Casini, Claudia Montagna in Nature Communications (2017)

  5. Article

    Open Access

    Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations

    Davide Prandi, Sylvan C. Baca, Alessandro Romanel in Genome Biology (2017)

  6. No Access

    Article

    Clonal evolution of chemotherapy-resistant urothelial carcinoma

    Mark Rubin, Francesca Demichelis and colleagues study the evolution of urothelial carcinomas by performing whole-exome sequencing of tumors collected from patients before and after chemotherapy. They find mark...

    Bishoy M Faltas, Davide Prandi, Scott T Tagawa, Ana M Molina in Nature Genetics (2016)

  7. No Access

    Article

    Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

    Genome-wide DNA methylation analysis of metastatic biopsies from patients with castration-resistant prostate cancer reveals marked epigenetic differences between samples with adenocarcinoma and neuroendocrine ...

    Himisha Beltran, Davide Prandi, Juan Miguel Mosquera, Matteo Benelli in Nature Medicine (2016)

  8. Article

    Open Access

    ASEQ: fast allele-specific studies from next-generation sequencing data

    Single base level information from next-generation sequencing (NGS) allows for the quantitative assessment of biological phenomena such as mosaicism or allele-specific features in healthy and diseased cells. S...

    Alessandro Romanel, Sara Lago, Davide Prandi, Andrea Sboner in BMC Medical Genomics (2015)

  9. Article

    Open Access

    Unraveling the clonal hierarchy of somatic genomic aberrations

    Defining the chronology of molecular alterations may identify milestones in carcinogenesis. To unravel the temporal evolution of aberrations from clinical tumors, we developed CLONET, which upon estimation of ...

    Davide Prandi, Sylvan C Baca, Alessandro Romanel, Christopher E Barbieri in Genome Biology (2014)